Apidra (Sanofi-Aventis U.S. LLC)
Welcome to the PulseAid listing for the Apidra drug offered from Sanofi-Aventis U.S. LLC. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi-Aventis U.S. LLC |
| NON-PROPRIETARY NAME: | insulin glulisine |
| SUBSTANCE NAME: | INSULIN GLULISINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-02-24 |
| END MARKETING DATE: | 0000-00-00 |
Apidra HUMAN PRESCRIPTION DRUG Details:
| Item Description | Apidra from Sanofi-Aventis U.S. LLC |
| LABELER NAME: | Sanofi-Aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([iU]/mL) |
| START MARKETING DATE: | 2009-02-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0088-2500_0d84194d-1f87-442c-ba43-5803e2d137dc |
| PRODUCT NDC: | 0088-2500 |
| APPLICATION NUMBER: | NDA021629 |
Other INSULIN GLULISINE Pharmaceutical Manufacturers / Labelers:
